Orlando, FL, United States of America

Russel G Higbee

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Vaxdesign Corporation. Active years: 2011.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Russel G Higbee

Introduction

Russel G Higbee is an accomplished inventor based in Orlando, FL (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on developing methods that enhance the understanding and efficacy of vaccine candidates.

Latest Patents

Russel G Higbee holds a patent titled "Methods of evaluating a test agent in a diseased cell model." This invention relates to constructing an integrated artificial immune system that mimics the tissues of the immune system in mammals. The artificial immune system is designed to test the efficacy of vaccine candidates and other materials in vitro. This advancement is crucial for accelerating vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response. He has 1 patent to his name.

Career Highlights

Higbee is associated with Sanofi Pasteur Vaxdesign Corporation, where he applies his expertise in immunology and vaccine development. His work at the company has been instrumental in advancing research in the field.

Collaborations

Some of his notable coworkers include William L Warren and Eric Mishkin, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Russel G Higbee's innovative work in developing an artificial immune system represents a significant advancement in vaccine research and development. His contributions are vital for the future of immunology and public health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…